Biotech · Private company
MyoKardia, Inc.
Track this companyFree. Adds MyoKardia, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- mavacamtenPhase 3 · Obstructive Hypertrophic CardiomyopathyClinicalTrials.gov · fetched Nov 12, 2026
- mavacamtenPhase 2 · Non-obstructive Hypertrophic CardiomyopathyClinicalTrials.gov · fetched Nov 12, 2026
- MYK-461Phase 2 · Cardiomyopathy, Hypertrophic ObstructiveClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic CardiomyopathyPHASE3 · COMPLETED · started May 29, 2018ClinicalTrials.gov NCT03470545 · fetched Nov 12, 2026
- A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)PHASE2 · COMPLETED · started Mar 30, 2018ClinicalTrials.gov NCT03442764 · fetched Nov 12, 2026
- A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract ObstructionPHASE2 · COMPLETED · started Aug 1, 2016ClinicalTrials.gov NCT02842242 · fetched Nov 12, 2026